Field Trip Health has received conditional approval to list on the NASDAQ, symbol "FTRP".
Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta
Levitee Labs announces definitive agreements to acquire 3 specialized pharmacies, a "leading telehealth provider", and 5 addiction clinics.
Red Light Holland Announces Updated Cash Position of Approximately $30 Million
Red Light Holland reports an updated position in cash and cash equivalents of roughly CAD$30 million following its merger with Creso Pharma.
Psyched Wellness Successfully Completes Its Largest Extraction and Shipment of AME-1 to Asia
Psyched Wellness announces the largest extraction and shipment of its flagship nootropic (AME-1) to Asia.
Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds
Mydecine files a new patent application in support of its MDMA-based psychedelic drug research.
Small Pharma Establishes Psychedelic-assisted Therapy Training Program
Small Pharma is starting its DMT-based training program for psychedelic-assisted therapy with its Phase IIa clinical trial due to start immediately.
Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States
Novamind seeks to increase access for U.S. investors through its OTC application.
The Other Magic Mushroom: Why a Canadian Startup Is Suddenly Interested in the Fungus From Super Mario
Psyched Wellness wants to bring the Amanita muscaria fungus to the masses.
The Mental Health Crisis Now Dwarfs Covid-19
The Mental Health Crisis is not only a much larger pandemic than the Covid-19 pandemic. It is also much deadlier.
Psilocybin induces rapid and persistent growth of neural connections in the brain’s frontal cortex, study finds
Yale scientists have found that a single dose of psilocybin given to mice induces a rapid and long-lasting increase in connections between pyramidal neurons in the medial frontal cortex, an area of the brain known to be involved in control and decision-making.
Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results
Field Trip Health Ltd., a leader in the development and delivery of psychedelic therapies, reported its fiscal first quarter 2022 results for the three months ended June 30, 2021.
The Mental Health Crisis Is Also A Suicide Epidemic
Every 10 minutes, someone in the United States commits suicide -- a suicide epidemic. Psychedelic drugs have the known potential to address and reverse this epidemic.